484 related articles for article (PubMed ID: 30705715)
1. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.
Desai A; Sandhu S; Lai JP; Sandhu DS
World J Hepatol; 2019 Jan; 11(1):1-18. PubMed ID: 30705715
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
Plaz Torres MC; Bodini G; Furnari M; Marabotto E; Zentilin P; Strazzabosco M; Giannini EG
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486355
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in the non-cirrhotic liver.
Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
Clin Hemorheol Microcirc; 2022; 80(4):423-436. PubMed ID: 34842182
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma and monitoring of high-risk patients.
Kaya E; Daniel Mazzolini G; Yilmaz Y; Canbay A
Hepatol Forum; 2022 Jan; 3(1):33-38. PubMed ID: 35782375
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.
Gawrieh S; Dakhoul L; Miller E; Scanga A; deLemos A; Kettler C; Burney H; Liu H; Abu-Sbeih H; Chalasani N; Wattacheril J
Aliment Pharmacol Ther; 2019 Oct; 50(7):809-821. PubMed ID: 31475372
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.
Thompson SM; Garg I; Ehman EC; Sheedy SP; Bookwalter CA; Carter RE; Roberts LR; Venkatesh SK
Br J Radiol; 2018 Dec; 91(1092):20180345. PubMed ID: 30074820
[TBL] [Abstract][Full Text] [Related]
7. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
9. The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
Lin MT; Chang KC; Chou YP; Tseng PL; Yen YH; Wang CC; Tsai MC; Cheng YF; Eng HL; Wu CK; Hu TH
J Gastroenterol Hepatol; 2015 Feb; 30(2):345-51. PubMed ID: 25092265
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia.
Hui S; Nguyen A; Le S; Dev A; Bell S
Intern Med J; 2024 Apr; ():. PubMed ID: 38666599
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
Terada T; Terasaki S; Nakanuma Y
Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
[TBL] [Abstract][Full Text] [Related]
13. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
[TBL] [Abstract][Full Text] [Related]
15. Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review.
Liu Y; Li H; Ye N; Luo CJ; Hu YY; Wu H; Gong JP
Med Sci Monit; 2019 Sep; 25():6615-6623. PubMed ID: 31479436
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
Wong SW; Ting YW; Chan WK
JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
[TBL] [Abstract][Full Text] [Related]
18. Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.
Gambarin-Gelwan M
Chin Clin Oncol; 2013 Dec; 2(4):32. PubMed ID: 25841911
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview.
Dănilă M; Sporea I
Med Ultrason; 2014 Jun; 16(2):139-44. PubMed ID: 24791845
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
